Dyne Therapeutics, Inc. (DYN): Price and Financial Metrics


Dyne Therapeutics, Inc. (DYN): $13.74

-0.31 (-2.21%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DYN to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

DYN Stock Price Chart Interactive Chart >

Price chart for DYN

DYN Price/Volume Stats

Current price $13.74 52-week high $15.63
Prev. close $14.05 52-week low $4.30
Day low $13.70 Volume 114,812
Day high $14.07 Avg. volume 283,642
50-day MA $12.68 Dividend yield N/A
200-day MA $10.45 Market Cap 716.22M

Dyne Therapeutics, Inc. (DYN) Company Bio


Dyne Therapeutics, Inc. operates as a biotechnology company. The Company focuses on transforming the lives of people with serious diseases by developing muscle-targeted therapies. Dyne Therapeutics offers its services in the United States.


DYN Latest News Stream


Event/Time News Detail
Loading, please wait...

DYN Latest Social Stream


Loading social stream, please wait...

View Full DYN Social Stream

Latest DYN News From Around the Web

Below are the latest news stories about DYNE THERAPEUTICS INC that investors may wish to consider to help them evaluate DYN as an investment opportunity.

TipRanks ‘Perfect 10’ List: Strong Catalysts Confirm the Bull Thesis on These 2 Stocks

All investors are after gains, but in trying to find the right stocks to increase a portfolio’s value, are constantly inundated with massive amounts of data. Thus, separating the wheat from the chaff is an arduous process but there are tools to help make sense of it all. TipRanks’ Smart Score is one. The tool collects all the info needed on any given stock and sorts it out into 8 different categories, all known to impact future performance. Combining those factors, they are then distilled into a

Yahoo | February 5, 2023

Diving Into Dyne Therapeutics (NASDAQ:DYN)

Dyne Therapeutics, Inc. has enjoyed a recent bounce from good news from a rival, more than tripling in price. Click here to see our take on DYN stock.

Seeking Alpha | January 19, 2023

Zacks Industry Outlook Highlights Dyne Therapeutics, Silence Therapeutics, Alaunos Therapeutics, Assertio Holdings and Acer Therapeutics

Dyne Therapeutics, Silence Therapeutics, Alaunos Therapeutics, Assertio Holdings and Acer Therapeutics are part of the Zacks Industry Outlook article.

Yahoo | January 19, 2023

5 Stocks to Buy as the Drug Industry Bets Big on Innovation

Innovation is expected to continue driving growth in the Medical-Drugs industry in 2023. DYN, SLN, TCRT, ASRT and ACER may prove to be good additions to one's portfolio.

Yahoo | January 18, 2023

Dyne Therapeutics Inc. (NASDAQ:DYN) Up 66.82% Since 52-Week Low; YTD Rose 11.82% – Here’s What You Need To Do

Dyne Therapeutics Inc. (NASDAQ:DYN)’s traded shares stood at 0.44 million during the last session. At the close of trading, the stock’s price was $12.96, to imply an increase of 8.82% or $1.05 in intraday trading. The DYN share’s 52-week high remains $15.63, putting it -20.6% down since that peak but still an impressive 66.82% since … Dyne Therapeutics Inc. (NASDAQ:DYN) Up 66.82% Since 52-Week Low; YTD Rose 11.82% – Here’s What You Need To Do Read More »

Marketing Sentinel | January 14, 2023

Read More 'DYN' Stories Here

DYN Price Returns

1-mo 20.00%
3-mo 30.98%
6-mo 14.02%
1-year 99.13%
3-year N/A
5-year N/A
YTD 18.55%
2022 -2.52%
2021 -43.38%
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6959 seconds.